Thomas J. Garite, MD

• Professor Emeritus, Obstetrics and Gynecology
• University of California at Irvine
• Director of Research and Education for Obstetrix
• Pediatrix Medical Group
• Editor-in-Chief, American Journal of Obstetrics and Gynecology
• Steamboat Springs, Colorado

Hereditary demyelinating neuropathies infection white blood cell count buy flagyl without prescription, such as Charcot-Marie-Tooth disease antibiotic blue capsule purchase flagyl 200 mg with visa, do not show the latter two features antibiotics for sinus infection how long does it take to work flagyl 500 mg generic, which are only seen in acquired neuropathies antibiotics for uti and exercise purchase flagyl 500 mg overnight delivery. Axonal disease is characterized by modest slowing of velocities and more marked reduction in the amplitudes of the muscle and sensory action potentials virus blocker purchase 400 mg flagyl fast delivery. Enlarged and prolonged motor unit potentials indicate subsequent regeneration, which occurs after several weeks to months. Demyelination has a limited differential (Box 3) and often a better prognosis, because myelin can start to regenerate within a few days. Axonal regeneration proceeds at a far slower rate of 1 to 3 m/day, and nerves with proximal lesions must go a long distance to reinnervate their muscle and might never reach their goal. The yield of general testing for other vitamin deficiencies in polyneuropathy is relatively low. However, referral to a rheumatologist should be considered with a very high titer (>1:1280). Rates greater than 70 mm/hour tend to be more meaningful, particularly with a mononeuritis multiplex pattern. Serum protein electrophoresis lacks sensitivity, and immunofixation should be ordered if there is high suspicion of a paraproteinemia. If there is suspicion of amyloidosis, a rectal, abdominal fat, or sensory nerve biopsy can be undertaken. Sural nerve biopsy is reserved for difficult diagnostic situations because it causes a permanent area of numbness with possible dysesthesias over the biopsied area. Suspicion of vasculitis is the most common indication, but pathology can also be seen in leprosy and with tumor infiltrate. A distinct clinical picture has emerged, most commonly of a patient in the sixth or seventh decade manifesting with distal dysesthesias and possibly with mild weakness and sensory ataxia. These patients tend not to develop significant disability, and treatment is mainly for neuropathic pain. Patients present with progressive asymmetric distal weakness, often of the arm, without sensory loss and with less atrophy than would be expected for the degree of weakness. Diagnosis is supported by finding conduction blocks in sites not usually associated with compression. Prednisone is given 1 mg/kg/day until improvement, followed by a slow tapering of 5 mg every 2 to 3 weeks over a period of months. Refractory patients have been treated with repeated plasmapheresis treatments or immunosuppressive therapy with cyclosporine (Sandimmune). The Miller-Fisher variant is characterized by specific clinical features of sensory ataxia, areflexia, and ophthalmolplegia. About 5% to 10% have significant persistent disability, and the mortality rate is 5%. During early treatment, patients might require admission to intensive care, with close monitoring of pulmonary function tests for respiratory compromise. Diaphragmatic weakness correlates with neck flexion and extension and shoulder abduction. This is generally well tolerated, and adverse side effects such as myalgia, headache, or flu-like symptoms often resolve with a reduced infusion rate. Patients can present with a symmetric distal neuropathy, autonomic proximal diabetic neuropathy, mononeuritis multiplex, compressive and cranial neuropathies, and trunk polyradiculopathies. The exact etiology is unknown, but theories include a metabolic process involving aldose reductase, ischemic damage, or an immunologic disorder. Typical symptoms include lancinating pains or burning, worse at night, and possible dysautonomia. Treatment includes blood sugar control to limit progression and symptom control for neuropathic pain. Gabapentin (Neurontin)1 and tricyclic antidepressants are common choices (see later). Autonomic neuropathy is treated symptomatically, with fludrocortisone (Florinef)1 0. Proximal diabetic neuropathy (diabetic amyotrophy) manifests typically with unilateral pain in the anterior thigh followed by step-wise progression over weeks to months of quadriceps weakness, atrophy of the proximal leg muscles, and a reduced knee reflex, with occasional contralateral leg involvement. A short course of corticosteroids (prednisone1 50 mg/day for 1 week, then tapering by 10 mg/week) can be used to ease pain in severe cases, with close monitoring of the glucose level, but overall prognosis is quite good, ranging from 1 to 18 months of recovery phase (mean of 6 months) and partial or complete restoration of strength in approximately 70% of patients. Neuropathies associated with an immunoglobulin (Ig)M monoclonal protein (approximately 60%) are typically distal, demyelinating, and symmetric, whereas IgG (30%) and IgA (10%) gammopathies can be axonal or demyelinating. In terms of treatment, the distal demyelinating neuropathy of IgM paraproteinemias tends to be treatment refractory. Axonal neuropathies and IgM, IgG, or IgA gammopathies have a less clear relationship and are typically not responsive to treatment. Toxic and Nutritional Neuropathies Treatment of toxic and nutritional neuropathies involves detection and removal of the underlying cause. A thorough review of medications, occupational exposures, and nutritional risk factors is essential (Box 4). Incidence of neuropathy does not always correlate with the dosage and duration of exposure. For instance, amiodarone neuropathy has been reported with dosages as low as 200 mg/day and durations as short as 1 month. Symptoms might not improve, or might even worsen, for several weeks after the drug is stopped before improvement starts, a phenomenon known as coasting. Cisplatin can cause a neuropathy that overlaps in symptomatology with paraneoplastic sensory neuronopathy, and dapsone is associated with a motor axonopathy. Specific treatments for drug-induced neuropathies include cyano-cobalamin (vitamin B12)1 for nitrous oxide neuropathy and pyridoxine (vitamin B6)1 for hydralazine and isoniazid neuropathies. Glutamine7 and vitamin E1 300 mg twice a day has shown promise for paclitaxel neuropathy, and neuroprotective agents such as nerve growth factor are being investigated for cisplatin-induced neuropathy. One of the most common nutritional neuropathies is caused by thiamine deficiency and is associated with alcohol consumption of at least 100 g per day. Patients present with burning feet, and early alcohol abstinence and treatment with thiamine denotes better chance of recovery. Vitamin B12 deficiency is vital not to miss and can manifest with a subacute combined degeneration, whereby patients have a superimposed myelopathy and neuropathy (spasticity but reduced reflexes). Sudden-onset symptoms, particularly in the feet and hands simultaneously, are also suggestive. In later stages, patients might develop a distal symmetric polyneuropathy, although it is important to determine if this might be due to nucleoside reverse transcriptase inhibitors, nutritional deficiency, or infection. Cranial neuropathies, sensory neuronopathy, lumbosacral polyradiculopathies, and mononeuritis multiplex also occur. Tuberculoid leprosy leads to hypopigmented patches with loss of pain and temperature sensation. Lepromatous leprosy, a more severe form seen in immunosuppressed persons, can cause ulnar, common peroneal, and facial neuropathies. Treatment involves a long-term multidrug regimen of dapsone and rifampin (Rifadin). Herpes zoster can cause a postherpetic neuralgia, defined as pain persisting for more than 6 weeks after the rash appears. Early treatment with acyclovir (Zovirax) (800 mg five times daily for 7 days) can reduce the duration of the acute phase. Lyme disease, caused by Borrelia burgdorferi, begins with erythema migrans, followed by multifocal peripheral and cranial neuropathies, particularly facial diplegia. Early stages are treated with a 3week course of doxycycline1 100 mg twice daily, and intravenous penicillin G1 should be given in the late stages. A distal sensorimotor neuropathy is associated with many different tumors and seldom precedes tumor diagnosis. A sensory neuronopathy is less common, but often precedes tumor diagnosis, thus warranting a careful work-up. Lung, breast, ovary, and gastrointestinal tract cancers are the most likely associated types. It classically manifests with a painful mononeuritis multiplex with asymmetric patchy features, reflecting multifocal ischemic damage. In this case, a sural nerve biopsy might reveal fibrinoid necrosis and perivascular inflammation. Treatment needs to be carefully undertaken with intravenous methylprednisolone (Solu-Medrol)1 for 3 days followed by oral prednisone. Several classes of medications can be tried (Table 2), although it is important to counsel the patient that complete abolition of pain is unlikely. A trial period should be undertaken for at least 6 to 8 weeks before concluding that the patient does not respond. A combination of agents with different mechanisms can have an advantage over monotherapy for the nonresponsive patient. Serotonin and noradrenaline reuptake inhibitors such as amitriptyline1 (Elavil), imipramine1 (Tofranil), and clomipramine1 (Anafranil) may be marginally more effective than those with relatively selective noradrenergic effects such as desipramine and nortriptyline. Second-line antidepressants include venlafaxine1 (Effexor), bupropion1 (Wellbutrin), and the recently approved duloxetine (Cymbalta), which have the advantage of better tolerability due to less muscarinic, histaminergic, and -adrenergic affinity. Pregabalin (Lyrica) is a newer related agent that, unlike gabapentin, exhibits linear pharmacokinetics and can be initiated at a therapeutic dose without a long titration. Second-line choices include lamotrigine1 (Lamictal), carbamazepine1 (Tegretol), and topiramate1 (Topamax). Valproate1 (Depacon) and zonisamide1 (Zonegran) have limited evidence, and phenytoin1 (Dilantin) can cause neuropathy. Oxcarbazepine1 (Trileptal), like carbamazepine, slows the recovery rate of voltage-activated sodium channels, but it also inhibits high-threshold N-type and P/Q-type calcium channels and reduces glutamatergic transmission. As a result, it can modulate both peripheral and central neuropathic pain pathways, and several studies into its efficacy are under way. Capsaicin works by depleting substance P and can temporarily worsen pain by causing a burning sensation. Other agents for severe neuropathies include opioid agents, such as tramadol (Ultram), which has low-affinity binding for -opioid receptors coupled with mild inhibition of norepinephrine and serotonin reuptake. Slow-release opioids, such as oxycodone (OxyContin) 30 to 60 mg/day, can help, and risk of addiction is low in this population. Early identification and treatment of these conditions are necessary to maximize functional outcomes. Conservative estimates suggest that about 45% of stroke patients have moderate to severe disabilities requiring rehabilitation. The goals of stroke rehabilitation are to maintain and optimize medical management, to maximize functional recovery, to minimize disability, and to improve quality of life and participation in society. The rehabilitative approach endeavors to provide patient-centered care that is organized, comprehensive, and specific to the needs of the stroke patient. The concerted efforts of the patient, family, and rehabilitation team are essential for achieving these goals. Recovery after stroke can be a long and challenging process for the patient and the family. Although functional gains occur most rapidly in the first year after a stroke, additional motor recovery is possible beyond 1 year when patients are involved in targeted rehabilitation programs. The rehabilitation team is composed of rehabilitation physicians (physiatrists), other physicians such as neurologists and neurosurgeons, rehabilitation nurses, occupational therapists, physical therapists, speech and language pathologists, rehabilitation neuropsychologists, social workers, case managers, nutritionists, vocational counselors, and pharmacists. A goal of the acute inpatient rehabilitation team is discharging the patient to the least restrictive environment, ideally home. The severity of deficits in these major areas and the ability of the patient to tolerate therapy determine the appropriate rehabilitation setting. Determination of rehabilitation needs of patients being discharged after an acute stroke. Comprehensive inpatient rehabilitation Targeted outpatient therapy** * Must tolerate 1. To accomplish this goal, it is critical to evaluate family support and the home environment. Speech-language pathologists, physical therapists, and occupational therapists evaluate deficits in cognition, communication, deglutition, mobility, and activities of daily living. Stroke patients with mild deficits are able to return home with home or outpatient therapy services. Patients with moderate to severe strokes benefit from more intensive therapy in an institutional setting. Comprehensive inpatient rehabilitation is suitable for patients with moderate to severe deficits who can tolerate intensive rehabilitation (3 h/day for 5 days each week or 15 hours of therapy over a 7 day period). If the severity of deficits or medical comorbidities limits the ability of the patient to participate in intensive therapy, alternate settings can be considered. Often, it is limited by muscle atrophy, co-contraction of agonists and antagonists, and abnormal tone. Usually, motor recovery is preceded by the development of patterned muscle movements, or synergies. For instance, extension synergy patterns of the lower limb can augment rehabilitation because this position fosters early ambulatory therapy. Conversely, flexion synergy patterns in the upper extremity can significantly impair arm function. Rehabilitation of the patient with hemiparesis should concentrate on maintaining range of motion and improving strength and posturing. Exercise programs should incorporate functional use of the hemiparetic limb and weight bearing to promote limb recognition, better alignment, muscle elongation, and muscle tone reduction. Hemiparesis can lead to contracture, particularly when profound weakness is present, and contracture occurs most commonly in the wrist and ankle. Resting hand splints and solid ankle-foot orthoses can be used to maintain the limb in a neutral position. These devices can be used to prevent loss of motion, control muscle tone, and aid in positioning, particularly when wheelchairs are necessary.

The main side effects of topical steroid use are cataract formation and ocular hypertension infection urinaire symptmes generic flagyl 400 mg online, which can lead to glaucoma antibiotics used for tooth infection flagyl 200 mg amex. Untreated uveitis can cause the same side effects; therefore virus your computer has been blocked department of justice purchase flagyl 200 mg, inflammation needs be controlled promptly virus definition biology cheap flagyl 200 mg mastercard, and then the corticosteroids need to be tapered off as soon as possible without precipitating a recurrence bacteria mitochondria flagyl 500 mg with mastercard. There are specific uveitis entities that mandate the use of immunosuppression as first-line treatment (together with steroids initially). This is the most common eye problem encountered in the United States and includes such conditions as nearsightedness (myopia), farsightedness (hyperopia), astigmatism, and age-related loss of near vision (presbyopia). A person who is able to see without the aid of spectacles or contact lenses has minimal to no refractive error. A wide variety of techniques are available for correcting refractive errors and restoring visual function. The most common methods employ corrective eyewear, such as eyeglasses and contact lenses. In addition to these noninvasive modalities, several surgical procedures can also be used to treat these conditions. These surgical techniques range from minimally invasive procedures, such as laser vision can be divided to corneal and intraocular procedures. Whichever method is selected, the primary goal of every visioncorrecting procedure should be to choose the technique that is most appropriate for each patient. This article focuses on the various surgical options that are available for vision correction. To set the groundwork for this discussion, we begin with some background information on ocular anatomy, refractive errors, and the clinical assessment of visual function. Surgical correction options include surgical monovision, which is popularly used with presbyopic contact lens wearers, where one eye is corrected for distance vision and the other eye for near vision. Pathophysiology Background Although the human eye is a complex structure, from a conceptual standpoint, it can be thought to function much like a simple camera. In general, light enters the eye and needs to be focused on the center of the retina, or the fovea, to generate images. Light first enters through the cornea, a convex transparent window that performs approximately 66% to 75% of the focusing for the eye. The pupil is an aperture centered within the iris, a muscular diaphragm that controls the diameter of the pupil and thus the amount of light that continues into the eye. The lens is suspended by a network of hundreds of supporting cables called zonular fibers. These zonules insert into the ciliary body, a muscular ring that is a peripheral extension of the iris. Accommodation results from contraction of the ciliary muscle, which results in a decreased diameter of the ciliary ring, similar to a lens aperture of a camera. This loosens the zonules, which simultaneously reduces zonular tension on the lens, thereby causing the thickness and anterior curvature to increase, along with its amplified refractive power. After being focused by the lens, light passes through the transparent vitreous humor until it reaches the retina, which lines the inside of the back of the eye. The retina functions like the film in a camera, converting the focused image into an electrical signal that is transmitted to the brain via the optic nerve. Refractive Errors Emmetropia is the condition where the eye has essentially no refractive error and requires no correction for distance vision. Refractive errors result when the cornea and lens inadequately focus incoming light, resulting in blurred images projected onto the retina. The unit of measure for refractive error is the diopter (D), which for a thin lens (in air) is defined as the reciprocal of the lens focal length. In myopia, or nearsightedness, the focusing powers of the cornea are too strong or the axial length of the eye is too long, or both. The resulting image comes into focus anterior to the retina and is out of 7 Diseases of the Head and Neck ed ic in. The refraction, or bending, of light in the eye occurs through the cornea and the crystalline lens. To correct a myopic eye, its refractive power must be decreased by using a lens with negative refractive power, which weakens the focusing of light and redirects it toward the retina. The cornea is flatter and focuses too weakly or the axial length is too short (or both) in the hyperopic eye. The images from objects viewed at a distance are not yet in focus by the time they reach the retina. To see clearly, a hyperopic eye must accommodate to increase its lenticular power to bring distant objects into sharp focus. Because this requires contraction of the ciliary muscle, the farsighted eye is never at rest and must work even harder to see near objects clearly. In astigmatism, the eye has different refractive powers along different meridians; light entering in the vertical direction gets focused differently than light in the horizontal direction. Conceptually, it is easier to think of the astigmatic cornea or lens as shaped like a football rather than a basketball, with the meridian of steeper curvature having greater refractive power. The astigmatic eye produces a blurred image because essentially two focal points of images are being produced. To see near objects clearly, young distance-corrected eyes must accommodate to increase their refractive power. However, this ability progressively declines with age, usually reaching clinical significance in the 5th decade. Several factors have been implicated in this process, including loss of lens elasticity, decreased zonular tension, and altered ciliary muscle function. Although there is currently no way to reverse this natural consequence of aging, several vision-correction options are available to improve near vision in presbyopic persons. Accommodation, or the ability to focus at close range, occurs as the result of the contraction of the zonules and a change in shape to the crystalline lens. Myopia is the most common refractive error and affects about 35% of whites and 13% to 30% of African Americans. Approximately three-quarters of the American population older than 40 years have refractive errors greater than 0. This effectively leads to multiple focal points of light, which results in blurred images. In general, a higher prevalence of hyperopia and less myopia is observed with increasing age from about 45 to 65 years. This levels off with older age and is eventually followed by an increase in myopia at older ages, which is thought to largely be from cataract formation. Regarding the correction of refractive errors, about 150 million Americans currently use some form of eyewear to correct refractive errors at a cost of approximately $150 billion annually, including 36 million who use contact lenses. The excimer laser was developed in the 1970s and emits ultraviolet light at a wavelength of 193 nm. This particular wavelength has been found to accurately and efficiently ablate corneal tissue without causing thermal damage to the surrounding collagen. In myopia, the excimer laser treatment flattens the central cornea to decrease its focusing power. Conversely, for hyperopia, laser pulses are applied to the periphery, indirectly steepening the central cornea and thereby increasing its refractive power. Astigmatism is corrected by combining central and peripheral treatments to differentially steepen the flattest corneal meridian and flatten the steepest meridian. The flap thickness typically varies from about 100 to 180 m, as compared with a total corneal thickness that usually ranges from 500 to 600 m. The femtosecond laser uses ultrashort microscopic pulses of infrared light to define the lamellar flap. Also, there are significantly less flap-related complications, such as free (without flap hinge), partial, or buttonhole (doughnut-shaped) flaps. Postoperative medications usually include topical antibiotic and steroid eye drops for approximately 5 to 7 days. If during the surgery the patient moves the eye (fixation loss), the laser can focus on the wrong part of the eye (decentration of the laser treatment), which can degrade the postoperative vision creating a chromatic aberration called coma. However, more severe or refractory cases can require further intervention, such as suturing. Usually, the peripheral nests of epithelial cells are small and insignificant visually, thus requiring no intervention. Larger collections of cells can compromise vision or cause corneal necrosis and scarring, so they need to be removed. This treatment might e need to be supplemented with alcohol or suturing, or both, to prevent recurrence. Corneal weakening and subsequent distortion are other potential sequelae of laser vision correction. Certain preoperative corneal shapes suggest a predisposition toward weakening, especially those with steeper curvature in the inferior region as compared with the superior region. The most common assessment of visual function is to test the central vision through visual acuity. This reference distance approximates optical infinity and is typically 20 feet in the United States and 6 meters in Europe. A 20/ 20 letter on the standard eye chart devised by Snellen is approximately three-eighths of an inch tall at a distance of 20 feet (subtending a visual angle of 5 minutes of arc). Visual acuities less than 20/20 are represented by ratios whose denominator is greater than 20. For example, a visual acuity of 20/60 means that the smallest letter the eye can read is three times larger than a 20/20-size letter. Refractive errors can result in uncorrected visual acuities that fall below 20/20. However, in the absence of other disease, the conditions of myopia, hyperopia, astigmatism, and presbyopia can be corrected with restoration of normal visual function. This can be achieved with spectacles, contact lenses, or the various surgical procedures discussed next. Staphylococcal and streptococcal species are most common, but atypical organisms such as mycobacteria and fungi have also been reported. Sterile inflammation can also occur in the flap interface and is known as diffuse lamellar keratitis. Diffuse lamellar keratitis has been associated with bacterial endotoxin, cleaning solutions, corneal abrasions, and excessive femtosecond laser energy levels. Treatment primarily relies on topical steroid eyedrops, but it may also include oral steroids and irrigation of the flap interface. In this method, the laser treatment is applied directly to the anterior stromal surface after the surface epithelium is removed. Each of these methods has certain advantages and disadvantages, but all do an effective job of preparing the corneal surface for laser ablation. Once the laser treatment is complete, a soft contact lens is placed on the cornea. The corneal epithelium typically heals in 4 to 7 days, after which the contact lens is removed. Once the contact lens is removed, recovery of vision can take a few more weeks, although some patients experience improvement in vision that continues over several months. Antibiotic eye drops are used until the contact lens is removed, and steroid eye drops may be tapered over several months. This development is usually associated with higher myopic corrections and may be reversed by increased application of topical steroid eyedrops. Shortduration intraoperative use of low-concentration topical mitomycin-C (Mitosol)1 (0. The increased dryness appears to be temporary, and most patients return to baseline by 6 to 9 months, but a subset of patients experience chronic dry eyes following the procedure. Radial keratotomy was the first modern form of refractive surgery for the correction of myopia. Up to 16 spokelike cuts radiating from the central cornea at 90% to 95% of corneal depth can be created to flatten the central cornea and balloon the peripheral cornea to correct myopia. In American Academy of Ophthalmologists: Focal Points, Clinical Modules for Ophthalmologists, February, 2008. In both procedures, incisions are made to a 90% to 95% depth in the cornea to flatten the steep meridian. The basic principles of astigmatism correction hold true for both types of keratotomy surgeries: a greater effect is achieved with longer incisions, with smaller optical zones, with deeper incisions, and in older patients. Because the incisions are made closer to the limbus, they heal faster, and thus the refractive effect stabilizes more quickly. Given their peripheral location, the ratio of flattening in meridian of incision-to-steepening ratio in the opposite meridian, or coupling ratio, is usually 1:1. Patients experience less irregular astigmatism, flare, and foreign body sensation as compared to their more central counterparts. Corneal relaxing incisions are most commonly performed intraoperatively, at the time of cataract surgery, but are also performed as a separate procedure to treat corneal astigmatism. The procedure is fairly quick to perform and the patient experiences little discomfort. Postoperatively, a topical antibiotic is used for 4 to 7 days, and a topical analgesic is used as needed. Regarding complications of corneal relaxing incisions, patients commonly experience a foreign body sensation during the first few days. Less-common complications include glare, undercorrection or overcorrection, irregular astigmatism from the incisions, wound gape or perforation, decreased corneal sensation, and dry eye syndrome.

Flagyl 200 mg purchase. Inside a chicken #2: food safety and antibiotic resistance HD.

Catharanthus (Madagascar Periwinkle). Flagyl.

• How does Madagascar Periwinkle work?
• Are there safety concerns?
• Dosing considerations for Madagascar Periwinkle.
• Diabetes, cancer, fluid retention, cough, lung congestion, sore throat, eye irritation, skin infections, and other conditions.
• What is Madagascar Periwinkle?

Source: http://www.rxlist.com/script/main/art.asp?articlekey=96629

Head-to-head studies can favor a single drug virus outbreak buy flagyl master card, but there is no consistent evidence for superiority of one drug over another antibiotic hepatic encephalopathy flagyl 400 mg purchase otc. Most side effects are experienced at the start of therapy and can be avoided by starting with a low enough dosage and increasing more slowly than recommended by the manufacturer virus software order flagyl 200 mg mastercard. Drug levels can provide a general guide and can help guide dosage increases by warning that toxicity can occur with further increases if levels are in the upper limit of the established therapeutic range virus kawasaki 400 mg flagyl with mastercard. If seizure control is not improved or side effects occur at low dosages virus 2014 september buy flagyl 250 mg line, then checking a serum level can help to uncover unexpectedly low levels due to fast metabolism or noncompliance, a problem especially common among adolescents. Ultimately, management decisions should be based on clinical history and not serum drug levels. After a minimum 2-year seizure-free period, a trial of drug withdrawal may be considered in certain patients, especially in those with an unknown etiology. Drug withdrawal is usually not logical in patients who have an epilepsy syndrome with a known lifelong tendency to seizures, such as juvenile myoclonic epilepsy. Mechanism of action is thought to be through use-dependent sodium channel blockade. The metabolism of phenytoin is saturable, which means that it shows zero-order kinetics at high blood levels. Very steep elevations in the blood level can occur with even small dosage increases when the blood level is near 20 g/mL, despite the occurrence of a linear increase in blood level with dosage increases when blood levels are below 20 g/mL. For example, the blood level may be 10 g/mL with 200 mg/day and then increase to 15 g/mL with 300 mg/day and then increase to 20 g/mL with 400 mg/day, but with an increase to 500 mg/day the level might skyrocket to more than 30 g/mL if metabolism is saturated. Cumulative side effects of phenytoin occur over many years and include gum hypertrophy, hirsutism, coarsening of features, ataxia due to cerebellar atrophy, peripheral neuropathy, and osteoporosis. All patients on phenytoin should receive calcium and vitamin D because phenytoin induces the metabolism of vitamin D, thus lowering its level and causing osteoporosis. Phenytoin is prone to drug­drug interactions, and it increases clearance of oral contraceptives and decreases their effectiveness. Intravenous phenytoin solution is very basic (pH 11), which often causes venous irritation and can cause purple glove syndrome and severe acute necrosis leading to amputation. Intravenous phenytoin is mixed in polyethylene glycol, causing bradycardia and hypotension, which limits the rate of infusion to less than 50 mg/ minute. This can be a significant problem in the treatment of status epilepticus or frequent seizures. Fosphenytoin (Cerebyx) is a phenytoin prodrug in which the phosphate group is rapidly cleaved off upon entering the bloodstream, yielding phenytoin. It is mixed in an aqueous solution and has a more neutral pH; thus it is much better tolerated and can be given as fast as 150 mg/minute. It also undergoes autoinduction, inducing its own metabolism for up to 3 weeks after initiating it, so that steady-state blood levels are not achieved for several weeks. Carbamazepine has a relatively narrow therapeutic window, with usual therapeutic blood levels of between 4 g/mL and 12 g/mL. It commonly causes acute toxicity (ataxia, diplopia, and lethargy) with only a small increase in the dosage. Carbamazepine does not have cumulative side effects, but it rarely causes serious idiosyncratic side effects including blood dyscrasias, hepatitis, and hyponatremia. Mild leukopenia is common and does not require intervention unless the white blood cell count falls below 3000 per mm3. Like phenytoin, it increases the clearance of oral contraceptives and decreases their effectiveness. It can be dosed once per day and has a very long half-life, which is an advantage in poorly compliant patients. Primidone (Mysoline) is an infrequently used prodrug of phenobarbital that also has its own antiseizure effects but less often causes lethargy. It is usually well tolerated, but occasionally it causes nausea, anorexia, headache, and blood dyscrasias. It can be dosed once per day because of its very long half-life, but it is usually better tolerated dosed twice daily. However, it can cause aplastic anemia and fulminant hepatitis, so it is only indicated for intractable epilepsy, in cases where the potential benefit outweighs the risk of potentially fatal side effects. Gabapentin Gabapentin (Neurontin) is very well tolerated and has no pharmacokinetic interactions because it is renally excreted unchanged. It is most commonly used for primary generalized seizures such as in juvenile myoclonic epilepsy1 and syndromes with absence seizures, but it is also effective for focal seizures. Sodium divalproex is immediately cleaved to valproate in the stomach, but this preparation has much better gastrointestinal tolerance. Valproate is usually dosed every 8 hours because of its relatively short half-life. Valproate is available as an intravenous preparation (Depacon), dosed identically to the oral forms. Valproate is usually well tolerated, but it occasionally causes weight gain, alopecia, tremor, and thrombocytopenia. It has been suggested that L-carnitine (levocarnitine, Carnitor)1 supplementation might reduce the risk of hepatitis. Although this has not been demonstrated, it is prudent for children who have unknown causes of mental retardation and who are taking valproate to take carnitine. Of even greater concern is that valproate is more often associated with neural tube defects such as spina bifida. Folic acid supplementation at 4 mg/day is recommended because it reduces the risk of neural tube defects in all pregnant women. Valproate is a poor choice for women of childbearing potential, and if they are on valproate, they should use an effective method of birth control and take folic acid. However, clinical experience suggests that dosages of as much as 3600 mg/day may be required to be effective for most patients. On the other hand, very high dosages might not increase blood levels because drug absorption may be saturated at dosages above 4000 mg/day. Lamotrigine Lamotrigine (Lamictal) is particularly useful because it is effective for partial seizures, generalized seizures, and Lennox-Gastaut syndrome. When taken alone (or with a combination of an enzyme inducer and inhibitor), the half-life of lamotrigine is about 25 hours, but this is reduced to 12 hours when it is taken with enzyme inducers (such as phenytoin, phenobarbital, carbamazepine) and prolonged to as much as 60 hours when taken with valproate, an enzyme inhibitor. Oral contraceptives decrease the half-life to 12 hours, necessitating dosage adjustment. Mild rash is common and was present in as many as 1 in 50 children and 1 in 1000 adults during initial clinical studies. The rash can be life threatening in the form of Stevens­Johnson syndrome or toxic epidermal necrolysis, but the incidence of serious rash, as lamotrigine is used today, is probably only about 1 in 40,000. The rash is most likely to occur after the first 3 weeks of therapy, but it can occur at any time, and it is most common with high initial doses and titration rates and when taken with valproic acid. In fact, the rate is so slow that patients are unlikely to see an effect for many weeks or months and can require encouragement from the physician. When a rash is reported, the patient must be examined immediately, and serious consideration must be given to stopping the drug. Levetiracetam Levetiracetam Keppra is very well tolerated and has not been associated with serious side effects. It occasionally causes significant irritability and/or depression that necessitates stopping the drug. It can be titrated relatively rapidly so that its effectiveness in a patient can be determined in a short time. It is primarily excreted unchanged, so it does not have significant drug interactions. Levetiracetam is available in an intravenous preparation, dosed the same as the oral form. Topiramate Topiramate (Topamax) is effective for partial seizures and some types of generalized seizures, especially the Lennox­Gastaut syndrome. The source of this is probably the design of clinical studies, which appropriately determined the maximum tolerated dose by finding the dose at which an unacceptable incidence of side effects occurs. Considering all topiramate clinical studies together, the incidence of subject dropout in those treated with more than 400 mg/day was twice that of the group treated with less than 400 mg/day, which was approximately equal to dropout in the placebo group. This indicates that the average maximum tolerated dose is about 400 mg/day, so it should usually be used at a dose lower than this. Topiramate is a weak carbonic anhydrase inhibitor and can cause kidney stones and metabolic acidosis; the use of other carbonic anhydrase inhibitors is relatively contraindicated. Acute narrow-angle glaucoma has been reported in a few cases and requires immediate discontinuation. Zonisamide Zonisamide (Zonegran) appears to be effective for both focal and some generalized1 epilepsies. Its pharmacology is not well described, but it is metabolized by multiple mechanisms and has a very long half-life, which might allow it to be dosed once per day. It also can cause oligohydrosis (reduced sweating) and has rarely been associated with blood dyscrasias. Pregabalin Pregabalin (Lyrica) is approved as adjunctive treatment of partial seizures in adults. Vigabatrin Vigabatrin (Sabril) is approved for infantile spasms in children ages 1 month to 2 years and for adult use in combination with other medications to treat complex partial seizures that have not responded adequately to previous drug therapies. Peripheral visual field defects can be seen in about 25% to 50% of adults and about 15% of children. Therefore it is recommended to have cognitive and age-appropriate vision testing at baseline and repeated at intervals. If there is significant reduction in seizures or the patient becomes seizure free, then the continuation of therapy depends on the risk-tobenefit ratio, and the patient or the caregiver should be involved in decision making. Rufinamide Rufinamide (Banzel) is approved as adjunctive therapy for seizures associated with Lennox­Gastaut syndrome, a severe form of epilepsy. The proposed mechanism of action is the limitation of sodium-dependent action potential firing. There seem to be a good cognitive and psychiatric adverse effect profile and few drug interactions. Rufinamide use is most appropriate when Lennox­Gastaut patients have failed other therapies. Oxcarbazepine cannot undergo this conversion and thus does not produce this metabolite. Therefore, it is better tolerated than carbamazepine and is less likely to cause diplopia and ataxia, although it is not clear whether it causes less sedation. The incidence of blood dyscrasias also appears lower than with carbamazepine, but hyponatremia seems more common than with carbamazepine. It is effective as monotherapy, so it is likely that in the future oxcarbazepine will entirely replace carbamazepine. Tiagabine Tiagabine (Gabitril) is approved as add-on therapy for partialonset seizures. It has a unique mechanism of action with selective enhancement of voltage-gated sodium channel slow inactivation. Lacosamide has a favorable pharmacokinetic profile with near 100% bioavailability, minimal protein binding, and few drug­drug interactions. The most common adverse effects include diplopia, headache, dizziness, and nausea. Clobazam Clobazam (Onfi) was recently approved in the United States for adjunctive treatment of seizures associated with Lennox­Gastaut syndrome. The most common adverse effects are sedation related (sedation, somnolence, drowsiness). It is primarily metabolized in the liver, and thus dosing should be adjusted in those with hepatic impairment. Ezogabine Ezogabine (Potiga), a potassium-channel opener, is approved as an adjunctive treatment of partial-onset seizures in adults. Urinary retention was reported in approximately 2% of patients in clinical trials. This drug should therefore be limited only to patients who have failed several alternative treatments and for whom the benefits outweigh the potential risk of vision loss. All patients taking ezogabine should have baseline and periodic (every 6 months) visual monitoring by an ophthalmic professional. It is believed to act through preferential blockade of voltage-gated sodium channels in rapidly firing neurons, but there may be additional mechanisms of action. Common side effects include dizziness, drowsiness, headache, nausea, and diplopia. Women with epilepsy have increased rates of infertility due to intrinsic hormone changes, anovulatory cycles, irregular menstrual cycles, and sexual dysfunction. Dose adjustments are recommended in those with mild and moderate hepatic impairment, and the drug should not be used in patients with severe hepatic or renal impairment, including those on hemodialysis. Common side effects include dizziness, somnolence, headache, fatigue, irritability, gait disturbance and falls. There is a boxed warning of serious neuropsychiatric effects including alteration of mood and aggression. Patients should be reassured that more than 90% of women with epilepsy have normal, healthy children. Therefore it should not be used as a first-line treatment in women of childbearing potential. All women of childbearing potential, with or without epilepsy, should take at least 0. Primidone (Mysoline) and levetiracetam probably transfer into breast milk in amounts that may be clinically important, whereas valproate, phenobarbital, phenytoin, and carbamazepine likely do not.

Preventive Services Task Force found insufficient evidence to support early detection through routine screening of asymptomatic persons virus reproduction buy 250 mg flagyl with amex. A third uncommon cause of hypothyroidism that should not be overlooked is secondary hypothyroidism due to hypothalamic or pituitary dysfunction virus 0xffd12566exe buy generic flagyl 400 mg on-line. These conditions are seen primarily in patients who have received intracranial irradiation or surgical removal of a pituitary adenoma antibiotic treatment for sinus infection order flagyl 200 mg visa. Finally antibiotic resistance quizlet discount flagyl 400 mg buy on-line, a variety of other conditions including infiltration of the thyroid (amyloidosis antibiotic zeocin buy flagyl master card, sarcoidosis), iodine deficiency, or medications (such as amiodarone [Cordarone] or interferon) can cause hypothyroidism. The thyroid examination in most patients with hypothyroidism is completely normal. Patients might have a painless goiter; tenderness in the thyroid is generally a sign of active inflammation consistent with acute thyroiditis. Once the thyroid inflammation has subsided, thyroid function might return to normal. Other physical findings that can occur with hypothyroidism include low blood pressure, bradycardia, nonpitting edema, generalized hair loss especially along the outer third of the eyebrows, dry skin, and a lag in the relaxation phase of reflexes that can be assessed most easily in the ankle jerk reflexes. One situation where clinicians need to be wary is evaluating thyroid status in patients who are severely ill. This condition, called euthyroid sick syndrome, does not require treatment with thyroid replacement and resolves within a few weeks of recovery, but it may be difficult to distinguish from preexisting or newonset hypothyroidism. Clinicians need to use other clinical symptoms to try to differentiate euthyroid sick syndrome from hypothyroidism. Even though it does not require treatment, the presence of euthyroid sick syndrome in a critically ill patient is a poor prognostic sign. In contrast to hyperthyroidism, there is no role for thyroid scans or iodine uptake testing in patients with hypothyroidism. The only exception to this is when the clinician identifies a mass on physical examination. In that situation, scanning or other imaging is essential to determine the malignancy potential of the mass. Diagnosis in e- vi de os Most of the complications of hypothyroidism are associated with undertreatment or overtreatment. Clinicians should be aware of these associations and not overlook new endocrine disorders that might have clinical features similar to hypothyroidism. Clinicians should educate patients about the need to have newly enlarged lymph nodes evaluated and be aggressive about evaluating symptoms or signs consistent with the development of a lymphoma. This includes conditions that lower serum protein levels, such as liver disease, nephrotic syndrome, or malnutrition, as well as those where serum proteins are increased, such as pregnancy or initiation of estrogen therapy. Obesity is a complex disease that represents a growing epidemic in the United States and worldwide. In the United States, the prevalence of obesity is highest in non-Hispanic black women. Most of the complications of hypothyroidism are associated with undertreatment or overtreatment. Patients with inadequately treated hypothyroidism are at higher risk for cardiac disease. On the other hand, over-replacement of thyroxine increases the risk of both atrial fibrillation and osteoporosis. Patients with subclinical hypothyroidism also might benefit from annual retesting of their free T4 levels. Approximately 10% of patients with subacute hypothyroidism progress to hypothyroidism within 3 years of diagnosis. Also, 50% of patients with subacute hypothyroidism have positive anti-thyroid antibodies; however, routine testing for these is not recommended. In some studies with elderly patients, subjects with continued neurocognitive dysfunction benefited from the addition of T3 at a dose of 125 g, with a concomitant decrease in the T4 dose of 50 g. However, subsequent studies of younger patients (aged 29­44 years) failed to find any benefits of partial T3 substitution. At this time, routine use of T3 cannot be recommended; however, for selected elderly patients who have lingering confusion, depression, or slow mentation on adequate doses of T4, a trial of T3 partial substitution might be tried. This condition, called subacute hypothyroidism or mild hypothyroidism, is more common in white elderly women. A waist circumference of >80 cm in Asian females and >90 cm in Asian males is considered abnormal. The prevalence of obesity has increased among women from 2005 to 2014 but has not changed in men. There are disparities in the prevalence of obesity between ethnic groups, especially among women. The American Medical Association recently officially classified obesity as a disease due to its association with several comorbidities and increased mortality. Increased waist circumference can also be a marker for increased risk even in persons of normal weight. Because people with abdominal (central) adiposity are more likely to develop many of the health conditions associated with obesity, waist circumference is an important adjuvant measurement to obtain when screening for obesity. Waist circumference is measured at the level of the top of the iliac crest with the measuring tape snug against the skin. More precise measurement of abdominal fat can be made with abdominal computed tomography or magnetic resonance imaging. Alternative methods to assess body composition and degree of fatness include measurements of skin fold thickness, hydrostatic weighing, bioelectric impedance, and scanning by dual-energy x-ray absorptiometry. These methods require specialized equipment and trained personnel and are not used routinely in clinical practice. Many factors, including genetic and environmental influences, can contribute to the development of obesity. However, personal decisions regarding food choices, portion sizes, and level of activity also contribute to body size. Because many medications promote weight gain, including several antipsychotics, antidepressants, antiepileptics, sulfonylureas, and steroids (Table 2), it is prudent to obtain a complete medication history from any patient who is being evaluated for obesity. Associated Comorbidities 5 Endocrine and Metabolic Disorders ic in Type 2 Diabetes the increasing prevalence of obesity has also resulted in an increasing prevalence of type 2 diabetes. More than 80% of type 2 diabetes can be attributed to obesity, but other factors, such as family history, are also involved. Criteria for the diagnosis of type 2 diabetes include a fasting glucose level greater than 125 mg/dL or glucose levels greater than 200 mg/dL during a 2-hour oral glucose tolerance test. Hypertension Hypertension is a common chronic disease, and it has been estimated that obesity is a major risk factor for hypertension. Hypertension is associated with an increased risk for stroke, myocardial infarction, heart failure, and kidney disease. Even a modest weight loss (5%­10% of initial weight) can lead to a significant fall in blood pressure and, often, decreased need for antihypertensive medications. Coronary Heart Disease Comorbidities associated with obesity such as hypertension, insulin resistance, type 2 diabetes, and dyslipidemia lead to increased risk of cardiovascular disease in obese adults. Respiratory Abnormalities Obstructive sleep apnea is the most important respiratory problem associated with obesity. Patients may present with snoring, apneic episodes, excessive daytime somnolence, fatigue, irritability, and erectile dysfunction. Consequent nocturnal hypoxemia may result in arrhythmias, pulmonary hypertension, and right-sided heart failure. Treatment includes weight loss and use of continuous positive airway pressure at night. Other alterations in pulmonary function that may occur, include higher residual lung volume associated with increased abdominal pressure on the diaphragm, decreased lung compliance and increased chest wall impedance, ventilation-perfusion abnormalities, reduced strength and endurance of respiratory muscles, depressed ventilatory drive, and bronchospasm. Gastroesophageal Disease Obesity is associated with an increased risk of gastroesophageal reflux disease symptoms as well as erosive esophagitis, esophageal adenocarcinoma, and gastric carcinoma. It has been suggested that increased intragastric pressure and relaxation of the lower esophageal sphincter from gastric compression from surrounding adiposity contributes to the reflux rather than the type of diet consumed. Additionally, obese men are at increased risk of death from stomach and prostate cancer, and obese women are at increased risk of death from cancers of the breast, uterus, cervix, and ovary. Psychosocial Function Obese subjects often are subjected to discrimination in education, employment, and health care. Overweight women have been noted to have lower household incomes and higher rates of household poverty than women who were not overweight, independent of their baseline socioeconomic status and aptitude test scores. Depression has also been seen in association with severe obesity, particularly in younger patients and in women. Osteoarthritis commonly develops in the knees and ankles but can also affect non­weight-bearing joints. Health care costs are higher in obese subjects compared to their normal weight counterparts. Treatment Patients must undergo a detailed history and physical examination before a treatment plan is initiated. A complete medication history is crucial to determining whether any medications may have promoted weight gain. Laboratory studies should be directed at ruling out secondary causes in selected patients and ruling out comorbidities (fasting glucose, lipid profile, liver function tests). Health care providers must enforce the idea that even a modest weight loss improves complications associated with obesity. Lifestyle modifications, including dietary change and increased physical activity, represent first-line treatment for patients with obesity. Pharmacotherapy and bariatric surgery may be used as adjuvant therapies in certain patients. The initial target goal of weight loss therapy is to decrease body er 1 Not available in the United States. The rationales for this initial goal of moderate weight loss are that: · It can decrease the severity of obesity-associated risk factors. A reasonable timeline for a 5% to 10% reduction in body weight is 6 months of therapy. Further weight loss may be considered if the initial goal is achieved and then maintained for at least 6 months. It is important to inform patients that it is preferable to maintain a moderate amount of weight loss over time than to lose more weight but later regain it. Behavior Modification Behavior modification is an integral part of any weight loss program. The goal of behavioral therapy is to help patients make longterm changes in their eating behavior by modifying and monitoring their food intake, increasing their physical activity, and controlling cues and stimuli in the environment that trigger eating. Maintaining food diaries and activity records for self-monitoring are key elements in any successful behavioral weight loss program. It focuses on gaining control over the environmental factors that activate eating and eliminating or modifying the environmental factors that facilitate overeating. This requires the availability of trained personnel such as psychologists and therapists. The behavioral strategies taught are aimed at decreasing caloric intake and increasing physical activity in the long term. Dietary Therapy the goal of dietary therapy, therefore, is to reduce the total number of calories consumed. A principal determinant of weight loss appears to be the degree of adherence to the diet, irrespective of the particular macronutrient composition. Recent data suggest that the so-called Mediterranean diet and low-carbohydrate diets may represent effective alternatives to the low-fat diet for weight loss. Thus, the macronutrient mix of the diet should be based upon patient preferences in order to improve long-term adherence. Often patients revert to their previous habit of eating and can regain the weight that was lost. Approximately 22 kcal/kg is required to maintain a kilogram of body weight in a normal adult. Thus, the expected or calculated energy expenditure for a woman weighing 100 kg is approximately 2200 kcal/day. The variability of Æ20% could give energy needs as high as 2620 kcal/day or as low as 1860 kcal/day. An average deficit of 500 kcal/day should result in an initial weight loss of approximately 0. However, after 3 to 6 months of weight loss, energy expenditure adaptations occur, which slow the body weight response to a given change in energy intake, thereby diminishing ongoing weight loss. Patients should be counseled to avoid unnecessary calories from alcohol and sugary beverages such as soda and juice. Very­low-calorie diets contain less than 800 kcal/day and are usually administered in the form of liquid supplements. Although these diets do produce significant and rapid weight loss, results are difficult to maintain in the long term. Side effects associated with very­lowcalorie diets include fatigue, constipation, hair loss, and gallstones. These diets are strictly contraindicated in children and in pregnant and lactating women and are generally reserved for patients who require rapid weight loss for a specific purpose such as surgery. These patients should have failed to achieve weight loss goals through diet and exercise alone. Pharmacotherapy must be used in conjunction with a program that includes dietary changes and physical activity. The success may be measured by the degree of weight loss and improvement in associated risk factors.

References

• Anderson G, et al. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp Neurol. 2007;207(1):4-12.
• Heintz C, Riepe G, Birken L, et al: Corroded nitinol wires in explanted aortic endografts: an important mechanism of failure? J Endovasc Ther 8:248-253, 2001.
• Martel MK, Sahijdak WM, Ten Haken RK, et al. Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 1998;40:155-161.
• Marcucci R, Gori AM, Paniccia R, et al: Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: A 12-month follow-up. Circulation 2009;119:237-242.
• Alfirevic Z, Neilson JP. Doppler ultrasonography in high-risk pregnancies: systematic review with metaanalysis. Am J Obstet Gynecol 1995; 172: 1379-87.
• Laffrey JG, Kavanagh BP: Carbon dioxide and the critically illótoo little of a good thing? Lancet 354:1283-1286, 1999.